Moderna increases minimum 2021 Covid vaccine production by 20% to 600 million doses


A health worker holds a Moderna COVID-19 vaccine bottle on the first day Orange County residents 65 and older can be vaccinated on December 29, 2020 at a drive through at the Orange County Convention Center in Orlando, Florida.

Paul Hennessy | NurPhoto | Getty Images

Moderna is increasing its Covid-19 vaccine production this year, increasing the expected minimum dose by 20% to 600 million, the company said on Monday.

The company claims it is working to produce up to 1 billion doses of its Covid-19 vaccine this year. The U.S. is well on track to secure 100 million doses of Moderna’s vaccine by the end of March and an additional 100 million by June, the Massachusetts-based company said in a statement.

The U.S. Food and Drug Administration granted Moderna’s emergency Covid-19 vaccine clearance for people aged 18 and over in the U.S. in December and began rolling out the drug for the first time.

The federal government has agreed to buy 200 million doses of the vaccine from Moderna, with an option to secure an additional 300 million doses, the company said.

This is a developing story. Please try again later.